Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Meier

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
Der Nervenarzt|July 17, 2004
[Doctor reports of a neurological clinic in the view of permanent resident neurologists and nerve doctors]G Niecke, A Abragam, C Beil, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 3, 2000
Efficacy of Daclizumab in an African-American and Hispanic renal transplant populationH U Meier-Kriesche, S S Palenkar, G S Friedman, et al.
Multiple Sclerosis and Related Disorders|May 1, 2022
German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practiseC Heesen, C Mokry, A Salmen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 13, 1999
Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal painB Kaplan, H U Meier-Kriesche, M G Jacobs, et al.
Transplantation|February 7, 2001
Increased immunosuppressive vulnerability in elderly renal transplant recipientsH U Meier-Kriesche, A Ojo, J Hanson, et al.
Transplantation|November 10, 1998
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantationB D Kahan, J Podbielski, K L Napoli, et al.
Journal of Clinical Pharmacology|July 7, 1999
The effect of renal insufficiency on mycophenolic acid protein bindingB Kaplan, H U Meier-Kriesche, G Friedman, et al.
Clinical Transplantation|October 26, 2000
The effect of Daclizumab in a high-risk renal transplant populationH U Meier-Kriesche, H Kaza, S S Palekar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2008
Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipientsB L Kasiske, A de Mattos, S M Flechner, et al.
Transplantation|August 10, 2000
African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategiesH U Meier-Kriesche, A Ojo, J C Magee, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
Der Nervenarzt|July 17, 2004
[Doctor reports of a neurological clinic in the view of permanent resident neurologists and nerve doctors]G Niecke, A Abragam, C Beil, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 3, 2000
Efficacy of Daclizumab in an African-American and Hispanic renal transplant populationH U Meier-Kriesche, S S Palenkar, G S Friedman, et al.
Multiple Sclerosis and Related Disorders|May 1, 2022
German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practiseC Heesen, C Mokry, A Salmen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 13, 1999
Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal painB Kaplan, H U Meier-Kriesche, M G Jacobs, et al.
Transplantation|February 7, 2001
Increased immunosuppressive vulnerability in elderly renal transplant recipientsH U Meier-Kriesche, A Ojo, J Hanson, et al.
Transplantation|November 10, 1998
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantationB D Kahan, J Podbielski, K L Napoli, et al.
Journal of Clinical Pharmacology|July 7, 1999
The effect of renal insufficiency on mycophenolic acid protein bindingB Kaplan, H U Meier-Kriesche, G Friedman, et al.
Clinical Transplantation|October 26, 2000
The effect of Daclizumab in a high-risk renal transplant populationH U Meier-Kriesche, H Kaza, S S Palekar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2008
Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipientsB L Kasiske, A de Mattos, S M Flechner, et al.
Transplantation|August 10, 2000
African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategiesH U Meier-Kriesche, A Ojo, J C Magee, et al.
Pageof 23